| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net revenue | $1.2M+814.1% | $135K | $0 | — | — | — |
| Cost of goods sold | $53K | $0 | $0 | — | — | — |
| Gross profit | $1.2M+774.8% | $135K | $0 | — | — | — |
| Research and development | $7.5M-17.4% | $9.1M+52.4% | $6.0M+138.6% | $2.5M-9.5% | $2.8M | — |
| General and administrative | $5.8M-34.2% | $8.9M+7.7% | $8.2M+19.1% | $6.9M+310.9% | $1.7M+32042.9% | $5K |
| Total operating expenses | $13.4M-25.7% | $18.0M+26.5% | $14.2M+22.4% | $11.6M+160.9% | $4.4M | — |
| Loss from operations | -$12.2M+31.8% | -$17.8M-25.6% | -$14.2M-22.4% | -$11.6M-160.9% | -$4.4M-84869.4% | -$5K |
| Interest income | $325K+221.8% | $101K | $0 | — | — | $12K |
| Interest expense | -$31K+87.3% | -$244K+77.4% | -$1.1M-71.6% | -$630K-197.2% | -$212K | — |
| Other financing costs | -$298K | $0 | — | — | — | — |
| Change in fair value of convertible notes | $0+100.0% | -$6.1M-14.2% | -$5.4M | $0 | — | — |
| Change in fair value of warrants liability | $32K+104.6% | -$697K-227.9% | $545K-95.0% | $10.9M+40333.3% | -$27K-102.3% | $1.2M |
| Total other income (expense), net | $28K+100.4% | -$7.0M+41.9% | -$12.0M-1972.8% | -$580K | — | — |
| Loss before provision for income taxes | -$12.1M+51.1% | -$24.8M+5.4% | -$26.2M-115.2% | -$12.2M-165.2% | -$4.6M | — |
| Provision for income taxes | $3K+0.0% | $3K | $0-100.0% | $1K+200.0% | -$1K | — |
| Net loss | -$12.2M+51.1% | -$24.8M+5.3% | -$26.2M-115.2% | -$12.2M-165.2% | -$4.6M | — |
| Net loss per share of common stock, basic and diluted (in dollars per share) | -$5.86+91.2% | -$66.33-119.2% | -$30.26-1944.6% | -$1.48-134.9% | -$0.63 | — |
| Weighted-average shares outstanding, basic and diluted (in shares) | 2.07B+453.8% | 374.4M+43087.6% | 867K-100.0% | 8.21B+13.4% | 7.24B | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.